Business
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body
ZUG, Switzerland, December 05, 2025--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its certification under the EU Medical Device Regulation (MDR). This expands Sculptra’s current clinical use on the face, to include four new areas: gluteal area, posterior thighs, décolletage, and upper arms. Sculptra can be used across these areas to address varied treatment goals – from imp
About this update from Galderma Group Ag
[{"type":"image","alt":"Sculptra Body Video","displaySize":"","headline":null,"caption":"Sculptra Body Video","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1920,"height":1080,"url":"https://media.zenfs.com/en/business-wire.com/986422f5e5dcd9bde36deb18c7c44fb3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2CcSY0Ex5bYsa_m.VBcBdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/986422f5e5dcd9bde36deb18c7c44fb3","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/PNzgDCZGEsf.MU6iXH_sYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/986422f5e5dcd9bde36deb18c7c44fb3","width":1200,"height":675}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/b2613d65ef3d04fd2a4d693664aecf0a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/emAx9roru9GDP5xDCINrxA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b2613d65ef3d04fd2a4d693664aecf0a","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/TmJL7jzgiSzS5Rk03g_V4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b2613d65ef3d04fd2a4d693664aecf0a","width":823,"height":209}}},{"type":"list","items":[{"val":[{"type":"text","content":"Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1","length":263,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour","length":231,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs","length...